You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

List of Excipients in API imatinib oral

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing imatinib oral

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Shorla Oncology Inc	IMKELDI	imatinib oral	81927-201	ACESULFAME POTASSIUM
Shorla Oncology Inc	IMKELDI	imatinib oral	81927-201	CITRIC ACID MONOHYDRATE
Shorla Oncology Inc	IMKELDI	imatinib oral	81927-201	GLYCERIN
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for imatinib oral

Excipient focus: ACESULFAME POTASSIUM

imatinib oral drug variants containing ACESULFAME POTASSIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Shorla Oncology Inc	imatinib oral	81927-201
>Company	>Ingredient	>NDC

imatinib oral drug variants not containing ACESULFAME POTASSIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CITRIC ACID MONOHYDRATE

imatinib oral drug variants containing CITRIC ACID MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Shorla Oncology Inc	imatinib oral	81927-201
>Company	>Ingredient	>NDC

imatinib oral drug variants not containing CITRIC ACID MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GLYCERIN

imatinib oral drug variants containing GLYCERIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Shorla Oncology Inc	imatinib oral	81927-201
>Company	>Ingredient	>NDC

imatinib oral drug variants not containing GLYCERIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTIC ACID

imatinib oral drug variants containing LACTIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Shorla Oncology Inc	imatinib oral	81927-201
>Company	>Ingredient	>NDC

imatinib oral drug variants not containing LACTIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MALTITOL

imatinib oral drug variants containing MALTITOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Shorla Oncology Inc	imatinib oral	81927-201
>Company	>Ingredient	>NDC

imatinib oral drug variants not containing MALTITOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM BENZOATE

imatinib oral drug variants containing SODIUM BENZOATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Shorla Oncology Inc	imatinib oral	81927-201
>Company	>Ingredient	>NDC

imatinib oral drug variants not containing SODIUM BENZOATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TRIACETIN

imatinib oral drug variants containing TRIACETIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Shorla Oncology Inc	imatinib oral	81927-201
>Company	>Ingredient	>NDC

imatinib oral drug variants not containing TRIACETIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

imatinib oral drug variants containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Shorla Oncology Inc	imatinib oral	81927-201
>Company	>Ingredient	>NDC

imatinib oral drug variants not containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.